MapLight Therapeutics, Inc.
MPLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$77,580 | -$55,709 | -$30,016 |
| Dep. & Amort. | $701 | $556 | $574 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 |
| Change in WC | -$3,065 | $2,041 | $1,723 |
| Other Non-Cash | $1,129 | $1,106 | $1,142 |
| Operating Cash Flow | -$78,815 | -$52,006 | -$26,577 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$770 | -$462 | -$746 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$125,018 | $0 | $0 |
| Inv. Sales/Matur. | $45,000 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | -$80,788 | -$462 | -$746 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | $0 |
| Stock Issued | $120,250 | $104,572 | $33,175 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | -$2,190 | $0 | $0 |
| Financing Cash Flow | $118,060 | $104,572 | $33,175 |
| Forex Effect | $27 | $0 | $21,813 |
| Net Chg. in Cash | -$41,516 | $52,104 | $27,665 |
| Supplemental Information | – | – | – |
| Beg. Cash | $79,769 | $27,665 | $0 |
| End Cash | $38,253 | $79,769 | $27,665 |
| Free Cash Flow | -$79,585 | -$52,468 | -$27,323 |